| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 745 | 2021 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 132 | 2018 |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 97 | 2021 |
| Gender differences in liver disease and the drug-dose gender gap E Buzzetti, PM Parikh, A Gerussi, E Tsochatzis Pharmacological Research 120, 97-108, 2017 | 95 | 2017 |
| Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group S Pape, RJ Snijders, TJG Gevers, O Chazouilleres, GN Dalekos, ... Journal of hepatology 76 (4), 841-849, 2022 | 85 | 2022 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 71* | 2022 |
| Outcome of COVID‐19 in patients with autoimmune hepatitis: an international multicenter study C Efe, R Dhanasekaran, C Lammert, B Ebik, F Higuera‐de la Tijera, ... Hepatology 73 (6), 2099-2109, 2021 | 69 | 2021 |
| Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis C Corpechot, O Chazouillères, P Belnou, AJ Montano-Loza, A Mason, ... Journal of hepatology 73 (3), 559-565, 2020 | 66 | 2020 |
| Coronavirus disease 2019 in autoimmune hepatitis: a lesson from immunosuppressed patients A Gerussi, C Rigamonti, C Elia, N Cazzagon, A Floreani, R Pozzi, ... Hepatology communications 4 (9), 1257-1262, 2020 | 65 | 2020 |
| Real-world experience with obeticholic acid in patients with primary biliary cholangitis D D’Amato, A De Vincentis, F Malinverno, M Viganò, D Alvaro, M Pompili, ... JHEP Reports 3 (2), 100248, 2021 | 57 | 2021 |
| Immune-mediated drug-induced liver injury: immunogenetics and experimental models A Gerussi, A Natalini, F Antonangeli, C Mancuso, E Agostinetto, ... International Journal of Molecular Sciences 22 (9), 4557, 2021 | 47 | 2021 |
| Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis YS de Boer, A Gerussi, FF van den Brand, GW Wong, N Halliday, ... Clinical Gastroenterology and Hepatology 17 (8), 1616-1624. e2, 2019 | 45 | 2019 |
| Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report RJ Andrade, GP Aithal, YS De Boer, R Liberal, A Gerbes, A Regev, ... Journal of hepatology, 2023 | 43 | 2023 |
| Measurement of gamma glutamyl transferase to determine risk of liver transplantation or death in patients with primary biliary cholangitis A Gerussi, DP Bernasconi, SE O'Donnell, WJ Lammers, H Van Buuren, ... Clinical Gastroenterology and Hepatology 19 (8), 1688-1697. e14, 2021 | 41 | 2021 |
| X chromosome contribution to the genetic architecture of primary biliary cholangitis R Asselta, EM Paraboschi, A Gerussi, HJ Cordell, GF Mells, RN Sandford, ... Gastroenterology 160 (7), 2483-2495. e26, 2021 | 37 | 2021 |
| The immunobiology of female predominance in primary biliary cholangitis A Gerussi, L Cristoferi, M Carbone, R Asselta, P Invernizzi Journal of Autoimmunity 95, 124-132, 2018 | 35 | 2018 |
| The role of macrophages in liver fibrosis: new therapeutic opportunities E Binatti, A Gerussi, D Barisani, P Invernizzi International journal of molecular sciences 23 (12), 6649, 2022 | 33 | 2022 |
| Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach L Cristoferi, V Calvaruso, D Overi, M Viganò, C Rigamonti, E Degasperi, ... Hepatology 74 (3), 1496-1508, 2021 | 33 | 2021 |
| Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis C Efe, C Lammert, K Taşçılar, R Dhanasekaran, B Ebik, ... Liver international 42 (3), 607-614, 2022 | 31 | 2022 |
| Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis CRH Hedin, G Sado, N Ndegwa, E Lytvyak, A Mason, A Montano-Loza, ... Clinical Gastroenterology and Hepatology 18 (10), 2295-2304. e2, 2020 | 27 | 2020 |
pietro invernizziProfessore di Gastroenterologia, University of Milan-Bicocca在 unimib.it 的电子邮件经过验证
